Depression screenings: Developing a model for use in a community pharmacy

Journal of the American Pharmacists Association

Volumn 48, Issue 1, 2008, Pages 46-51

  Hare, Sarah Kerner ^a   Kraenow, Kimberly ^b  

^a Hen House Pharmacy   (United States)

^b TAKEDA PHARMACEUTICALS   (United States)

Author keywords

Community pharmacy; Depression; Health screening

Indexed keywords

ARTICLE; EVALUATION; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PHARMACIST; PHARMACY; PILOT STUDY; PROFESSIONAL STANDARD; PSYCHOLOGICAL RATING SCALE; UNITED STATES;

COMMUNITY PHARMACY SERVICES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; KANSAS; MALE; MASS SCREENING; MIDDLE AGED; MISSOURI; PHARMACISTS; PILOT PROJECTS; PROFESSIONAL ROLE; PSYCHIATRIC STATUS RATING SCALES; REFERRAL AND CONSULTATION;

EID: 38749085736     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2008.07010     Document Type: Article

References (13)

1. Adler DA, Bungay KM, Wilson IB, et al. The impact of pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004;26:199-209.
2. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc. 2002;42:36-43.
3. Lane R, McDonald G. Reducing the economic burden of depression. Int Clin Psychopharmacol. 1994;9:229-43.
4. Knox ED, Dopheide JA, Wincor MZ, et al. Depression screening in a university campus pharmacy: a pilot project. J Am Pharm Assoc. 2006;46:502-6.
5. Saklad SR. Pharmacoeconomic issues in the treatment of depression. Pharmacotherapy. 1995;15:76S-83S.
6. American Psychiatric Association: Diagnosis and statistical manual of mental disorders. 4th ed., text revision. Washington, D.C: American Psychiatric Association;2000:349-417.
7. Murray CJ, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, Mass.: Harvard University Press;1996.
8. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA. 2003;289:3095-105.
9. Hirschfeld RM, Keller MB, Panico S, et al. The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA.1997;277:333-41.
10. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465-75.
11. Docherty J. Barriers to the diagnosis of depression in primary care. J Clin Psychiatry. 1997;58(suppl 1):5-10.
12. Pignone MP, Gaynes BN, Rushron JL, et al. Screening for depression in adults: a summary of the evidence for the preventive services task force. Ann Intern Med. 2002;136:765-76.
13. Baer L, Jacobs DG, Meszler-Reizes J, et al. Development of a brief screening instrument: the HANDS. Psychother Psychosom. 2000;69:35-41.